Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Milestone Pharmaceuticals Inc. MIST

Set alert

Price alert · MIST

All alert types
0.74 USD +0.02 +2.83%

As of Nov 3, 12:47 PM ET

Bid
0.74 × 2
Ask
0.74 × 4
0.72 Day range 0.7661
0.631 52-week range 3.06
YTD
-63.29%
1 year
-59.92%
Open
0.72
Prev close
0.7211
Mkt cap
92.33M
Vol
244.62K
Avg vol
1.35M
EPS
-0.68
P/E
0.00
Div yield
0.00%
More statistics
Low
0.72
High
0.7661
Forward P/E
-2.15
Beta
1.73
Short ratio
2.46
Inst. own
57.01%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.71
200-d avg
1.58
1y target
10.25

3M chart

Chart tools
Interval
1m5m15m30m

Signals (19)
NameDateAgo
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 29, 20265 days ago
MACD: Buy SignalOct 27, 20261 week ago
MACD: Sell SignalOct 26, 20261 week ago
MACD: Buy SignalOct 12, 20263 weeks ago
RSI: OversoldOct 6, 20264 weeks ago
RSI: OversoldSep 23, 20261 month ago
RSI: OversoldSep 16, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 3, 20262 months ago
SMA: BullishAug 25, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BullishAug 10, 20262 months ago
MACD: Buy SignalAug 4, 20263 months ago

Analyst view

Price target (mean) 10.25 +1282.3% upside
Target (low)
2.00
Target (mean)
10.25
Target (high)
25.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MIST analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.15-0.16 – -0.14-0.32+53.1%00.0%2
Next quarter-0.17-0.21 – -0.13-0.21+19.0%00.0%2
Current year-0.61-0.64 – -0.58-1.39+56.1%0-100.0%2
Next year-0.81-1.11 – -0.51-0.61-32.8%6.05M0.0%2

Upgrades and downgrades

The latest rating changes

MIST analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 22, 2024Rodman & RenshawInitiated—Buy
Jul 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 5, 2024Piper SandlerMaintainedOverweightOverweight
Feb 26, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 27, 2023TD CowenMaintainedOutperformOutperform
Aug 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 20, 2023JefferiesDowngradeBuyHold
May 23, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 12, 2023OppenheimerMaintained—Outperform
Mar 30, 2023HC Wainwright & Co.Reiterated—Buy
Mar 9, 2023HC Wainwright & Co.Reiterated—Buy
Nov 14, 2022HC Wainwright & Co.Maintained—Buy
Apr 22, 2022Piper SandlerUpgradeNeutralOverweight
Mar 5, 2021HC Wainwright & Co.Initiated—Buy
Jul 29, 2020OppenheimerUpgradePerformOutperform
Jul 24, 2020JefferiesUpgradeHoldBuy
Mar 25, 2020JefferiesDowngradeBuyHold
Mar 24, 2020OppenheimerDowngradeOutperformPerform
Mar 24, 2020Piper SandlerDowngradeOverweightNeutral
Jun 3, 2019JefferiesInitiated—Buy
Jun 3, 2019Piper SandlerInitiated—Overweight